CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-02 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +5,000 | $13.56 | $68K | 15,066 |
| 2025-09-02 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −4,895 | $70.24 | $344K | 10,171 |
| 2025-09-02 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −105 | $70.76 | $7K | 10,066 |
| 2025-09-02 | Lyon Joseph Douglas See Remarks | Grant or award 10b5-1 | +200 | $71.38 | $14K | 10,266 |
| 2025-09-02 | Lyon Joseph Douglas See Remarks | Grant or award 10b5-1 | +200 | 10,466 | ||
| 2025-09-02 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 26,571 | ||
| 2025-09-02 | Maduck Sean See Remarks | Option exercise 10b5-1 | +20,000 | $5.05 | $101K | 27,681 |
| 2025-09-02 | Maduck Sean See Remarks | Sale 10b5-1 | −15,070 | $70.38 | $1.1M | 12,611 |
| 2025-09-02 | Maduck Sean See Remarks | Sale 10b5-1 | −4,930 | $70.84 | $349K | 7,681 |
| 2025-09-02 | Maduck Sean See Remarks | Grant or award 10b5-1 | +228 | $71.38 | $16K | 7,909 |
| 2025-09-02 | Maduck Sean See Remarks | Grant or award 10b5-1 | +228 | 8,137 | ||
| 2025-09-02 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 1,986 | ||
| 2025-09-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −39,300 | $70.52 | $2.8M | 2,822,070 |
| 2025-09-02 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −700 | $71.01 | $50K | 2,821,370 |
| 2025-09-02 | Mokari Atabak Chief Financial Officer | Grant or award | +200 | $71.38 | $14K | 14,265 |
| 2025-09-02 | Mokari Atabak Chief Financial Officer | Grant or award | +200 | 14,465 | ||
| 2025-09-02 | Robb Gary Charles Chief Business Officer | Grant or award | +251 | $71.38 | $18K | 13,615 |
| 2025-09-02 | Robb Gary Charles Chief Business Officer | Grant or award | +251 | 13,866 | ||
| 2025-08-22 | Robb Gary Charles Chief Business Officer | Option exercise | +5,000 | $3.88 | $19K | 18,364 |
| 2025-08-22 | Robb Gary Charles Chief Business Officer | Sale | −2,326 | $71.27 | $166K | 16,038 |
Page 20 of 61 · 1,220 trades